Peer Review reports
From: Paxlovid reduces the 28-day mortality of patients with COVID-19: a retrospective cohort study
| Original Submission | ||
|---|---|---|
| 10 Aug 2023 | Submitted | Original manuscript |
| 6 Dec 2023 | Reviewed | Reviewer Report |
| 15 Jan 2024 | Reviewed | Reviewer Report |
| 1 Feb 2024 | Author responded | Author comments - Shuliang Guo |
| Resubmission - Version 2 | ||
| 1 Feb 2024 | Submitted | Manuscript version 2 |
| 2 Feb 2024 | Author responded | Author comments - Shuliang Guo |
| Resubmission - Version 3 | ||
| 2 Feb 2024 | Submitted | Manuscript version 3 |
| 9 Feb 2024 | Reviewed | Reviewer Report |
| 20 May 2024 | Reviewed | Reviewer Report |
| 2 Jun 2024 | Author responded | Author comments - Shuliang Guo |
| Resubmission - Version 4 | ||
| 2 Jun 2024 | Submitted | Manuscript version 4 |
| 3 Jun 2024 | Author responded | Author comments - Shuliang Guo |
| Resubmission - Version 5 | ||
| 3 Jun 2024 | Submitted | Manuscript version 5 |
| 5 Jun 2024 | Reviewed | Reviewer Report |
| Resubmission - Version 6 | ||
| Submitted | Manuscript version 6 | |
| Publishing | ||
| 6 Jun 2024 | Editorially accepted | |
| 1 Aug 2024 | Article published | 10.1186/s12879-024-09482-y |
You can find further information about peer review here.